Choice of an Optimal Diluent for Intravesical Bacillus Calmette-Guerin Administration
Author:
Affiliation:
1. From the Division of Urologic Surgery, Washington University School of Medicine and The Jewish Hospital of St. Louis, St. Louis, Missouri
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Urology
Reference16 articles.
1. Intracavitary bacillus Calmette-Guerin in the treatment of superficial bladder tumors;Morales;J. Urol.,1976
2. BCG vaccine in the treatment of noninfiltrating papillary tumours of the bladder;Martinez-Piñeiro,1980
3. The use of bacillus Calmette-Guerin in the therapy of bladder carcinoma in situ;Brosman;J. Urol.,1985
4. Single course versus maintenance bacillus Calmette-Guerin therapy for superficial bladder tumors: a prospective, randomized trial;Hudson;J. Urol.,1987
5. Complications of bacillus Calmette-Guerin immunotherapy in 1,278 patients with bladder cancer;Lamm;J. Urol.,1986
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Investigation of the causes of BCG refractory in patients treated with intracavitary BCG as secondary treatment in superficial bladder tumors with transurethral resection;International Urology and Nephrology;2022-01-15
2. A systematic review of preventive and therapeutic options for symptoms of cystitis in patients with bladder cancer receiving intravesical bacillus Calmette–Guérin immunotherapy;Anti-Cancer Drugs;2019-06
3. Intravesical bacillus Calmette-Guerin therapy: experience with a reduced dwell-time in patients with pronounced side-effects;BJU International;2005-12
4. AUTOCRINE OVER EXPRESSION OF FIBRONECTIN BY HUMAN TRANSITIONAL CARCINOMA CELLS IMPAIRS BACILLUS CALMETTE-GUERIN ADHERENCE AND SIGNALING;Journal of Urology;2004-10
5. Elevated urinary fibronectin levels after transurethral resection of bladder tumour: a possible role in patients failing therapy with bacillus Calmette-Guérin;BJU International;2001-12-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3